2021 Virtual Best of Breast

 

2021 Virtual Best of Breast
K

40 y/o Premenopausal Woman With mBC: Does LRT for the IPT Show Survival Benefit Following Initial Systemic Therapy?

By 2021 Virtual Best of Breast FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
By 2021 Virtual Best of Breast FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
0 views
January 25, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy
Videos
16:02
2021 Virtual Best of Breast

Case Study of Premenopausal Woman With HR+, HER2- MBC: What Does the…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
08:26
2021 Virtual Best of Breast

HR+/HER2- MBC: What Are the Biopsy and 1L Treatment Options Using NC…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
14:15
2021 Virtual Best of Breast

Breast Cancer Genetic Testing: What Are the Most Common Mutations? W…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
15:59
2021 Virtual Best of Breast

Optimizing Genetic Testing for BC: Who & When Should Get Tested?

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
17:37
2021 Virtual Best of Breast

PARPi for BC With Germline Mutations: Why Are They Good Option for B…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
08:46
2021 Virtual Best of Breast

BC Risk Management: Should We Be Offering Testing to Everyone? Do We…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
13:34
2021 Virtual Best of Breast

BC Cascade Testing: How Can Patients Use Testing to Inform Their Fam…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
06:14
2021 Virtual Best of Breast

Combatting Endocrine Resistance in BC: Use of Integrated Medicine Ap…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
19:31
2021 Virtual Best of Breast

Endocrine Decision Making in BC: OFS+Tamoxifen/Exemestane - What Pro…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
06:18
2021 Virtual Best of Breast

40 y/o Premenopausal Woman With mBC: Does LRT for the IPT Show Survi…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
09:19
2021 Virtual Best of Breast

BC Side Effects: What Are the Key Points That Need to Be Assessed at…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
07:34
2021 Virtual Best of Breast

Postmenopausal Woman With Triple-Positive Breast Cancer: How to Appr…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
22:46
2021 Virtual Best of Breast

56 y/o Postmenopausal Woman With Triple-Positive BC: Estrogen Depriv…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
10:46
2021 Virtual Best of Breast

BC Side Effects & Survivorship: What Are the Most Common AI-Rela…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
13:24
2021 Virtual Best of Breast

BC & Menopause Side Effects: Cardio-Toxicity, Cardiac Sparing Ra…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
06:12
2021 Virtual Best of Breast

BC Side Effects: Cost of Cancer Care - Determinants, Effects & B…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
12:07
2021 Virtual Best of Breast

40 y/o Premenopausal Woman With Palpable Right Breast Mass: Should W…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
21:39
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Is IDFS Better With ET Alone o…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
21:08
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Does PMRT After ALND Reduce th…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
09:37
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Does OFS+Exemestane Improve DR…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
14:59
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Can Tamoxifen Reduce Mortality…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
21:20
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Genetic Counseling/Testing, Bilateral Breas…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
14:28
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Can We Achieve pCR With Pembro/Atezo? What …

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
07:08
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: What Is the FNR of SLN Surgery After Chemo?…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
03:22
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Does Adjuvant Capecitabine Improve DFS Afte…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
10:19
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Is Atezo+Nab-Paclitaxel Beneficial for PFS/…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
09:43
2021 Virtual Best of Breast

2021 Update on New Agents for mTNBC: ADCs (Sacituzumab Govitecan, La…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
09:00
2021 Virtual Best of Breast

59 y/o Woman With HER2+ Invasive Ductal Carcinoma: Is Neoadjuvant Tr…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani
12:44
2021 Virtual Best of Breast

59 y/o Woman With HER2+ EBC: Should We Choose T-DM1 as Post-Neoadjuv…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani
11:19
2021 Virtual Best of Breast

HER2+ mBC Case Study Discussion: PFS Data of Tucatinib + Trastuzumab…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani
22:37
2021 Virtual Best of Breast

Case Study Discussion on HER2+ MBC: Trastuzumab Deruxtecan in Heavil…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani